论文部分内容阅读
子宫肉瘤是一组来源于子宫间质、结缔组织或平滑肌的恶性肿瘤,是一种少见的妇科恶性肿瘤,其恶性程度高,易复发及远处转移,预后不佳。子宫肉瘤的治疗以手术为主,其他治疗方式包括放疗、化疗、激素治疗及分子靶向治疗等。其中,化疗在子宫肉瘤治疗中发挥重要的作用。化疗作为一种全身性的治疗,可消除早期微小转移病灶,减少肿瘤的远处转移。近年来,随着对化疗的不断认识和研究,术后辅助以化疗为主的全身治疗已日益受到重视。
Uterine sarcoma is a group of uterine stromal, connective tissue or smooth muscle malignant tumors, is a rare gynecological malignancy, its high degree of malignancy, recurrence and distant metastasis, the prognosis is poor. Uterine sarcoma surgery mainly surgery, other treatments include radiotherapy, chemotherapy, hormone therapy and molecular targeted therapy. Among them, chemotherapy plays an important role in the treatment of uterine sarcoma. Chemotherapy, as a systemic treatment, eliminates early-stage micrometastases and reduces distant metastases. In recent years, with continuous understanding and research of chemotherapy, postoperative adjuvant chemotherapy-based systemic therapy has drawn increasing attention.